We're doing a really good job preventing capsular contracture, and a lot of that is because we are doing a better job of preventing biofilms.
A biofilm is a low-grade, subclinical infection — a collection of bacteria living somewhere in your body, usually on something that doesn't have a good blood supply or has no blood supply at all. The bacteria essentially hold hands, create a gooey protective coating, and hang out there. Over time, they cause inflammation in the normal tissue surrounding them.
A common everyday example? Plaque on your teeth is a biofilm.
Biofilms can form on breast implants and all sorts of other implanted devices. On breast implants specifically, the bacteria involved are almost always:
These aren't aggressive bacteria that cause dramatic infections requiring ICU care. They're more subtle — which is exactly what makes biofilms tricky.
No. Many women with biofilms on their breast implants have zero symptoms. But for some women, biofilm does cause problems — and in particular, certain bacteria have been linked to capsular contracture:
Not every woman with these bacteria on her implant develops a contracture. There's still a lot we don't understand about who gets capsular contracture and who doesn't — but biofilm is clearly a contributing factor.
You'll often hear in the breast implant community that biofilm causes symptoms associated with breast implant illness (now called systemic symptoms from breast implants, or SSBI).
Here's what the data shows:
The breast surgery community has gotten much better at preventing biofilms, which is a big reason capsular contracture rates have dropped so dramatically. Current prevention strategies include:
The results are impressive: the most recent data from Allergan shows a capsular contracture rate of less than 2% — a huge improvement over historical rates of 10–15%.
Biofilms are common, often harmless, but can contribute to capsular contracture in certain patients. Modern surgical techniques focused on biofilm prevention have dramatically reduced contracture rates. If you're considering breast augmentation or are dealing with implant complications, understanding biofilm is an important part of the conversation with your surgeon.
Every person deserves to feel comfortable and confident in their own body. Our procedures aren't just about physical change. They're about reclaiming your life, your comfort, and your self-assurance.
Dr. Killeen and her team support you every step of the way, from your first consultation through recovery.
Take the first step toward the life you deserve.
Schedule Your ConsultationEvery person deserves to feel comfortable and confident in their own body. Our procedures aren't just about physical change. They're about reclaiming your life, your comfort, and your self-assurance.
Dr. Killeen and her team support you every step of the way, from your first consultation through recovery.
Take the first step toward the life you deserve.
Schedule Your ConsultationRelated Articles

How Surgeons Actually Prevent Implant Infection and Biofilm in the OR
October 14, 2025
Dr. Killeen walks through the specific OR techniques used to minimize the risk of infection and biofilm in breast implant surgery — from the Keller Funnel and NAC shields to irrigation solutions like hypochlorous acid and betadine, glove changes, and re-prepping the skin.

Capsular Contracture: Causes, Prevention, and Treatment
December 6, 2025
Dr. Killeen provides a comprehensive overview of capsular contracture — what causes it, how prevention has improved dramatically, and how modern treatment approaches are evolving.

Do Newer Implant Brands Really Have Lower Contracture Rates?
March 11, 2025
Newer implant brands advertise very low capsular contracture rates, but Dr. Killeen explains why the comparison is misleading: those numbers are usually benchmarked against early-2000s data from older brands, spanning twenty years of technique improvement. Older studies did not control for incision location, Keller funnel use, irrigation, or covering the nipple-areolar complex, all of which change contracture risk. Established brands show low rates in recent studies too, and rates have fallen field-wide from 10-15% to under 2%.